Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Secrier, M. et al. Nat. Genet. 48, 1131–1141 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Frankell, A. M. et al. Nat. Genet. 51, 506–516 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Li, X. et al. Nat. Commun. 9, 2983 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mourikis, T. P. et al. Nat. Commun. 10, 3101 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rahman, S. A. et al. Br. J. Surg. 107, 1042–1052 (2020).

    Article  CAS  PubMed  Google Scholar 

  6. Rogerson, C. et al. eLife 9, e57189 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature 578, 82–93 (2020).

    Article  CAS  Google Scholar 

  8. Nowicki-Osuch, K. et al. Science 373, 760–767 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Ococks, E. et al. Ann. Oncol. 32, 522–532 (2021).

    Article  CAS  PubMed  Google Scholar 

  10. Luebeck, J. et al. Nature 616, 798–805 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to R. C. Fitzgerald.

Ethics declarations

Competing interests

Grant funding for OCCAMS infrastructure was provided by Cancer Research UK. Project specific funding for commercial assay technologies applied to OCCAMS samples was provided by Roche and Natera. R.F. is a shareholder in Cyted Ltd, an early diagnosis company.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peters, C.J., Ang, Y., Ciccarelli, F.D. et al. A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium. Nat Med 30, 14–16 (2024). https://doi.org/10.1038/s41591-023-02676-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02676-y

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research